The 3rd Protein Degradation and Targeting Undruggables Summit is North America’s only in-person, industry-led conference covering clinical progress and commercial scale development of first-in-class degrader technology platforms.
Our agenda will cover the key drug development challenges for this therapeutic modality including assessing diverse targets, improving selectivity and delivery to disease-relevant proteins.
You will have the opportunity to engage with industry leaders tethering target-binding moieties, utilizing proteomics approaches to profile future drug candidates, progressing chimeric oligonucleotides enabling transcription-factor degradation and novel formats such as molecular glue degrades.
Download the agenda here: https://hubs.ly/Q013V2hZ0
This post was originally published on Source Link